Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Gastro-News
Erschienen in: Gastro-News 5/2023

16.10.2023 | Leberzirrhose | Fortbildung

Hepatologie - Teil 5 Patienten am Lebensende

Palliative Versorgung bei fortgeschrittenen Lebererkrankungen

verfasst von: Prof. Dr. med. Claus Niederau

Erschienen in: Gastro-News | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Auszug

Patienten mit schweren Lebererkrankungen benötigen oft eine palliative und hospizliche Betreuung, da sie in der Regel viele schwerwiegende Beschwerden, eine schlechte Lebensqualität und eine hohe Sterblichkeit haben. Dieser Artikel analysiert zu diesem Thema aktuelle Originalarbeiten, Reviews und Leitlinien - insbesondere aus den letzten fünf Jahren. …
Literatur
1.
Arney J, Gray C, Walling AM et al. Two mental models of integrated care for advanced liver disease: qualitative study of multidisciplinary health professionals. BMJ Open. 2022;12:e062836
2.
D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-31
3.
Woodland H, Hudson B, Forbes K, et al. Palliative care in liver disease: what does good look like? Frontline Gastroenterol. 2020;11:218-27
4.
Woodrell CD, Hansen L, Schiano TD, et al. Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults. Clin Ther. 2018;40:512-25
5.
Kimbell B, Murray SA, Byrne H et al. Palliative care for people with advanced liver disease: a feasibility trial of a supportive care liver nurse specialist. Palliat Med. 2018; 0269216318760441
6.
Goldberg DS, French B, Sahota G et al. Use of population-based data to demonstrate how waitlist-based metrics overestimate geographic disparities in access to liver transplant care. Am J Transplant. 2016;16:2903-11
7.
Bryce CL et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant. 2009;9:2092-101
8.
Kanwal F, Hernaez R, Liu Y et al. Factors associated with access to and receipt of liver transplantation in veterans with end-stage Liver disease. JAMA Intern Med 2021;181:949
9.
10.
11.
12.
Karlsen TH, Sheron N, Zelber-Sagi S et al. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet. 2022;399: 61-116
13.
Verma M, Tapper EB, Singal AG, Navarro V. Nonhospice palliative care within the treatment of end-stage liver disease. Hepatology. 2020;71:2149-59
14.
Tandon P, Walling A, Patton H, Taddei T. AGA clinical practice update on palliative care management in cirrhosis: expert review. Clin Gastroenterol Hepatol. 2021;19:646-56
15.
Verma M, Bakitas MA. Creating effective models for delivering palliative care in advanced liver disease. Curr Hepatol Rep. 2021;20:43-53
16.
Rogal SS, Hansen L, Patel A, et al. AASLD practice guidance: palliative care and symptom-based management in decompensated cirrhosis. Hepatology. 2022;76:819-53
17.
Baumann AJ, Wheeler DS, James M et al. Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. J Pain Symptom Manage. 2015;50:882-6
18.
Kimbell B, Murray SA, Byrne H et al. Palliative care for people with advanced liver disease: a feasibility trial of a supportive care liver nurse specialist. Palliat Med. 2018; 0269216318760441
19.
20.
Radbruch L et al. Standards und Richtlinien für Hospiz- und Palliativversorgung in Europa: Teil 1. Weißbuch zu Empfehlungen der Europäischen Gesellschaft für Palliative Care (EACP) Z Palliativmed. 2011;12:216-27
21.
Verma M, Kalman R, Horrow J et al. Feasibility of a Palliative Care Intervention within Routine Care of Hepatocellular Carcinoma: A Pilot Randomized Controlled Trial. J Palliat Med. 2023;26:334-41
22.
Kieffer SF, Tanaka T, Ogilvie AC et al. Palliative Care and End-of-Life Outcomes in Patients Considered for Liver Transplantation: A Single-Center Experience in the US Midwest. Am J Hosp Palliat Care. 2022:10499091221142841
23.
Ufere NN, Robinson B, Donlan J et al. Pilot Randomized Controlled Trial of an Advance Care Planning Video Decision Tool for Patients With Advanced Liver Disease. Clin Gastroenterol Hepatol. 2022;20:2287-95
24.
Rosenstengle C, Kripalani S, Rahimi RS. Hepatic encephalopathy and strategies to prevent readmission from inadequate transitions of care. J Hosp Med. 2022;17:17-23
25.
Johnson AW, Byriel B, Rubeck J et al. Standardized Criteria Increases Palliative Care Consultation Utilization in Patients With End-Stage Liver Disease: A Pilot Study. Am J Hosp Palliat Care. 2022:10499091221127984
26.
National End of Life Care Intelligence Network. Deaths from liver disease: implications for end of life care in England. https://​www.​ias.​rg.​uk/​uploads/​pdf/​News%20stories/nhs-endoflife-liverdisease-report.pdf
27.
Cross SH, Ely EW, Kavalieratos D et al. Place of Death for Individuals With Chronic Lung Disease. Chest. 2020;158:670-80
28.
Verma S, Verne J, Ufere NN. Palliative care in advanced liver disease: time for action. Lancet Gastroenterol Hepatol 2023;8:106-8
29.
Jordan RI, El Mokhallalati Y, Corless L, Bennett M. Quality of end-of-life care with non-malignant liver disease: Analysis of the VOICES National Survey of Bereaved People. Liver Int. 2023;43:308-16
30.
Ufere NN, Donlan J, Waldman L et al. Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease. Clin Gastroenterol Hepatol. 2019;17:2592-99
31.
Williams R, Ashton K, Aspinall R et al. Implementation of the Lancet Standing Commission on Liver Disease in the UK. Lancet. 2015;86:2098-111
32.
Low JTS, Rohde G, Pittordou K et al. Supportive and palliative care in people with cirrhosis: International systematic review of the perspective of patients, family members and health professionals. J Hepatol. 2018;69:1260-73
33.
Mohy-Ud-Din N, Syed A, Strahotin C, Babich M. Predictors and Outcomes of Palliative Care Consultations for Patients With Liver Disease: Results of a Cohort Study of 75 Million Medical Records. Am J Hosp Palliat Care. 2023:10499091231152229
34.
Gupta K, Hans B, Khan A et al. A retrospective study on use of palliative care for patients with alcohol related end stage liver disease in United States. World J Hepatol. 2022;14:1817-29
35.
Orman ES, Yousef A, Xu C et al. Palliative Care, Patient-Reported Measures, and Outcomes in Hospitalized Patients With Cirrhosis. J Pain Symptom Manage. 2022;63:953-61
36.
Patel A, Walling AM, Ricks-Oddie J et al. Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life. Clin Gastroenterol Hepatol. 2017;15:1612-19
37.
Wright M, Woodland H, Hudson B. Symptom control in advanced chronic liver disease: integrating anticipatory palliative and supportive care. Frontline Gastroenterol. 2022;13:e109-15
38.
Berry P, Kotha S. Improving end of life care in liver disease. J Hepatol. 2022;76:1225-6
39.
Thandassery RB, Sharma S, Syed M, Perisetti A. A global multicenter propensity-matched analysis of mortality risk and palliative care referral due to cirrhosis in hospitalized patients with COVID-19. J Clin Transl Res. 2022;8:414-20
40.
Tombazzi CR, Howe CF, Slaughter JC, Obstein KL. Rate of and Factors Associated with Palliative Care Referral among Patients Declined for Liver Transplantation. J Palliat Med. 2022;25:1404-8
41.
Whitsett MP, Ufere NN, Patel A et al. Palliative care experience and perceived gaps in training among transplant hepatology fellows: A national survey. Hepatol Commun. 2022;6:1680-8
42.
Serper M, Parikh ND, Thiele G et al. Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022;76:251-74
43.
Rakoski MO, Volk ML. Palliative care and end-stage liver disease: a critical review of current knowledge. Curr Opin Gastroenterol. 2019;35:155-60
44.
Ozdogan OC. Palliative care in cirrhotic patients: Brief summary of recent AASLD guidance. Hepatol Forum. 2022;3:100-2
45.
Niederau C. Betreuung von Zirrhosepatienten im Endstadium. Gastro-News. 2919;6:18
46.
Kimbell B, Boyd K, Kendall M et al. Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open. 2015;5:e009241
47.
Low J, Davis S, Vickerstaff V et al. Advanced chronic liver disease in the last year of life: a mixed methods study to understand how care in a specialist liver unit could be improved. BMJ Open. 2017;7:e016887
48.
Low point JTS, Rohde G, Pittordou K et al. Supportive and palliative care in people with cirrhosis: international systematic review of the perspective of patients, family members and health professionals. J Hepatol. 2018;69:1260-7
49.
Drysdale K, Rance J, Cama E et al. What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end-of-life: A scoping review. Health Soc Care Community. 2022;30:e3775-88
50.
Cross SH, Ely EW, Kavalieratos D et al. Place of death for individuals with chronic lung disease: trends and associated factors from 2003 to 2017 in the United States. Chest. 2020;158:670-80
51.
Aithal GP, Palaniyappan N, China L et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70:9-29
52.
Standing H, Jarvis H, Orr J et al. How can primary care enhance end-of-life care for liver disease? Qualitative study of general practitioners' perceptions and experiences. BMJ Open. 2017;7:e017106
Metadaten
Titel
Hepatologie - Teil 5 Patienten am Lebensende
Palliative Versorgung bei fortgeschrittenen Lebererkrankungen
verfasst von
Prof. Dr. med. Claus Niederau
Publikationsdatum
16.10.2023
Verlag
Springer Medizin
Erschienen in
Gastro-News / Ausgabe 5/2023
Print ISSN: 1869-1005
Elektronische ISSN: 2520-8667
DOI
https://doi.org/10.1007/s15036-023-3286-z

Weitere Artikel der Ausgabe 5/2023

Gastro-News 5/2023 Zur Ausgabe

Journal club

Änderungen zur Nomenklatur für Fettlebererkrankungen

Editorial

Bleiben Sie up to date

Info Pharm

HEMR und BU-Remission erreichbar

Journal club

Lactulose zur Behandlung von schlechter Lebensqualität bei Leberzirrhose

Info Pharm

Früher und gezielter Einsatz eines Biologikums bei CED

Aktuell

Mit "Verstand und Bauchgefühl"

Passend zum Thema

ANZEIGE

Synergien nutzen gegen Tumore

Magenkarzinom

Lungen- und Magentumore können dank Immuntherapien deutlich besser behandelt werden. Dennoch kommt es trotzdem weiterhin häufig zum Krankheitsprogress. Welche Therapieoptionen sich in der Zweitlinie am besten eignen, haben wir für Sie zusammengefasst.

ANZEIGE

Darmkrebsreihenuntersuchungen zeigen EU-weit Erfolge

Kolonkarzinom

In Europa haben viele Länder dem Darmkrebs mit Hilfe von Früherkennungsprogrammen den Kampf angesagt. Es gibt einen deutlichen Zusammenhang zwischen Inzidenz und Mortalität von Darmkrebs und der Zeitspanne seit Einführung von Reihenuntersuchungen.

ANZEIGE

GI-Tumore und die Rolle von Angiogenesehemmern

Content Hub

Entdecken Sie mit praxisrelevanten Patientenfällen, kompakten Studieninhalten, informativen Experteninterviews und weiteren spannenden Inhalten, wie Sie den vielseitigen Herausforderungen bei GI-Tumoren begegnen können. Hier erfahren Sie mehr! PP-RB-DE-2009

Bildnachweise